Sector: MedicalNoven Pharmaceuticals, Inc. (NASDAQ: NOVN)
Ranking History
Scan Date: | 11/17/2009 |
Sector: | Medical |
Funamental : | 186 |
Technical : | 107 |
Performance : | 110 |
Overall: | 127 |
Number of Stocks: | 307 |
Scan Date: | 11/10/2009 |
Sector: | Medical |
Funamental : | 180 |
Technical : | 67 |
Performance : | 98 |
Overall: | 89 |
Number of Stocks: | 306 |
Scan Date: | 11/3/2009 |
Sector: | Medical |
Funamental : | 185 |
Technical : | 60 |
Performance : | 103 |
Overall: | 88 |
Number of Stocks: | 306 |
Headlines
- REFILING: Hisamitsu to acquire U.S. pharmaceutical firm
Jul 14, 2009 11:04 AM | NOVN
- Hisamitsu to acquire U.S. pharmaceutical firm
Jul 14, 2009 11:03 AM | NOVN
- What's Your Stock's Price Target?
Jun 09, 2009 03:15 PM | AIRM, CNX, CWCO, NEM, NOVN
- Is BioSante Next In The Biotech Buyout Binge?
Nov 14, 2008 02:32 PM | BBI, BPA, NOVN
- Is It Time To Invest In Pharmaceuticals?
Aug 18, 2008 08:42 AM | AZN, BMY, FRK, GSK, LLY, MRK
- FDA Calendar: Buy CV Therapeutics and Sell Noven Pharma
Aug 07, 2008 02:05 AM | CVTX, MYL, NOVN
- UPDATE: Shire Recalls Some Daytrana Hyperactivity Patches
Jun 09, 2008 11:30 AM | NOVN
- UPDATE: Shire Recalls Some Daytrana Hyperactivity Patches
Jun 09, 2008 11:30 AM | NOVN
- NASDAQ Technical Picture - Hanging Man to End Bullish Week
May 19, 2008 01:56 AM | ADI, AEA, ANN, ARO, ARUN, ASPM
- Noven Appoints Michael D. Price Chief Financial Officer
Nov 15, 2007 05:29 PM | BNT, NOVN
- Hisamitsu to Acquire U.S. Pharmaceutical Firm
Jul 15, 2009 01:54 PM | NOVN
- Movers: AIG, Lehman, Healthways, LDK Solar, Noven Pharma
Aug 26, 2008 10:55 AM | AIG, AMD, BRCM, FNM, FRE, GILT
- Drug Industry Flexes Muscles in New Jersey
Aug 19, 2008 02:06 PM | AG, DNA, JNJ, NOVN, NVS, RHHBY
- Hisamitsu Pharmaceutical Announces Expiration of Subsequent Offering Period and Completion of Tender Offer for Outstanding Shares of Noven Pharmaceuticals
Aug 27, 2009 08:24 AM | NOVN
- Hisamitsu Pharmaceutical Announces Expiration of Initial Tender Offer Period for Outstanding Shares of Noven Pharmaceuticals and Commencement of Subsequent Offering Period
Aug 20, 2009 08:15 AM | NOVN
- Standard & Poor's Announces an Update to the U.S. Indices Liquidity Criteria and a Change to U.S. Index
Aug 18, 2009 05:50 PM | MHP, NOVN, SIGM
- Hisamitsu Pharmaceutical Announces Expiration of HSR Waiting Period for Its Proposed Acquisition of Noven Pharmaceuticals
Aug 13, 2009 02:52 PM | NOVN
- Hisamitsu Pharmaceutical Co., Inc. Begins Tender Offer for All Outstanding Shares of Noven Pharmaceuticals, Inc.
Jul 23, 2009 07:06 AM | NOVN
- Kendall Law Group Announces Lawsuit on Behalf of Noven Shareholders
Jul 22, 2009 02:13 PM | NOVN
- Law Offices of Howard G. Smith Announces Investigation On Behalf of Shareholders of Noven Pharmaceuticals, Inc.
Jul 15, 2009 12:52 AM | NOVN
- Noven and Hisamitsu Enter into Definitive Merger Agreement
Jul 14, 2009 06:56 AM | NOVN
- Noven Reports Positive Phase 2 Results for Mesafem™ Non-Hormonal Therapy for Vasomotor Symptoms
Jul 14, 2009 06:42 AM | NOVN
- Noven Announces Results of 2009 Annual Meeting of Stockholders
May 22, 2009 02:01 PM | NOVN
- Form 4 PRICE MICHAEL DENNIS For: Aug 27 (10K)
Aug 27, 2009 05:38 PM
- Form 4 Venditti Anthony For: Aug 27 (10K)
Aug 27, 2009 05:38 PM
- Form 4 Lippman Joel For: Aug 27 (10K)
Aug 27, 2009 05:35 PM
- Form 4 Gilbert Richard P. For: Aug 27 (10K)
Aug 27, 2009 05:33 PM
- Form 4 DINH STEVEN M For: Aug 27 (10K)
Aug 27, 2009 05:32 PM
- Form 4 EISENBERG JEFFREY F For: Aug 27 (10K)
Aug 27, 2009 05:30 PM
- Form 4 Brandt Peter C. For: Aug 27 (10K)
Aug 27, 2009 05:29 PM
- Form 4 Yetter Wayne P. For: Aug 27 (10K)
Aug 27, 2009 05:24 PM
- Form 4 Savage Robert G. For: Aug 27 (10K)
Aug 27, 2009 05:19 PM
- Form 4 SATOW PHILLIP M For: Aug 27 (10K)
Aug 27, 2009 05:16 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
NOVN
|
Compare to S&P
|
| YTD |
49.73 %
|
31.88 %
|
| 4 Weeks |
-0.42 %
|
-4.70 %
|
| 12 Weeks |
41.13 %
|
29.01 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: -14.29 %
|
|
EPS Growth in Last Year: 63.64 %
|
|
Sales Growth in Last Quarter: -3.15 %
|
|
Sales Growth in Last Quarter: 8.81 %
|
|
